How active is Private Equity / PE-Backed Roll-Up in healthtech acquisitions?

12 disclosed private equity / pe-backed roll-up acquisitions of healthtech businesses analyzed (6 from 2018+). Run the ExitValue.ai calculator to see what this buyer pool would pay for your specific business.

Who are the most active private equity / pe-backed roll-up buyers of healthtech businesses?

Top recent acquirers by deal count: Vista Equity Partners (2 deals), Thoma Bravo (2 deals), Altaris (1 deals), Patient Square Capital (1 deals), Nordic Capital / Insight Partners (1 deals), Veritas Capital/Evergreen Coast Capital (1 deals).

BUYER POOL ANALYSIS

Selling a Healthtech to Private Equity / PE-Backed Roll-Up buyers

Private equity firms and PE-backed platform consolidators acquiring for roll-up, add-on, or platform plays. Pricing tends to lead the market for fee-viable scale, with multi-bidder competitive processes above the EBITDA floor.

Quick answers

How many disclosed transactions?: 12 deals total (6 from 2018+), filtered to Private Equity / PE-Backed Roll-Up acquirers of healthtech businesses.
Most active buyers: Vista Equity Partners (2) · Thoma Bravo (2) · Altaris (1) · Patient Square Capital (1) · Nordic Capital / Insight Partners (1) · Veritas Capital/Evergreen Coast Capital (1)
What would this buyer pool pay for my business?: Run the ExitValue.ai calculator to see your healthtech priced against the 12 disclosed private equity / pe-backed roll-up transactions in this segment. The engine surfaces the specific multiples that apply to your size, margin, and growth profile.

Recent disclosed deals

Private Equity / PE-Backed Roll-Up acquisitions of healthtech businesses with named target and named acquirer.

Year	Target	Acquirer
2024	Model N	Vista Equity Partners
2024	Sharecare, Inc.	Altaris
2023	NextGen Healthcare	Thoma Bravo
2022	SOC Telemed	Patient Square Capital
2021	Inovalon	Nordic Capital / Insight Partners
2018	Athenahealth, Inc.	Veritas Capital/Evergreen Coast Capital

What this buyer pool prices for

Private equity acquirers price for scale and roll-up arbitrage. They pay up for businesses that fit a platform thesis - recurring revenue mix above 30%, technician/professional depth, clean financials, and a management layer that survives integration. A healthtech that fits the platform thesis prices materially above what an individual buyer would pay because PE is buying a platform piece, not an owner-operated shop.

Methodology note

Deal flow shown reflects disclosed M&A transactions in the ExitValue.ai database, filtered to healthtech businesses acquired by private equity / pe-backed roll-up buyers. Deal counts shown reflect deals with disclosed financials only - total transaction count for this buyer pool is typically 2-3x larger. The valuation engine reveals the specific multiples that apply to your business when you run the calculator above. Full methodology

What's your healthtech worth to private equity / pe-backed roll-up?

12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.

✓Sellability score with 5-driver breakdown and lift estimates
✓Named comparable M&A transactions in your sub-vertical
✓AI-written analysis grounded in your specific inputs

Run my valuation analysis →

Engine-grounded estimate. Comparable private equity / pe-backed roll-up deals on the full results page.